SUBSCRIBE
SUBSCRIBE
News   Business

CalciMedica Raising $4 Million Series C Round

December 18, 2008 | 
1 min read

CalciMedica Inc., a La Jolla, Calif.-based drug startup focused on autoimmune and inflammatory diseases, has secured $4 million of a $12 million Series C round, according to a regulatory filing.

Startups
MORE ON THIS TOPIC
Artist rendering of lab space
Real estate
Texas Life Sciences Redevelopment Project Moves Closer to Reality
August 29, 2024
 · 
1 min read
 · 
Angela Gabriel
Photo of a judge's gavel, a balance and a stack of papers
Legal
Regeneron Sues Sandoz in Federal Court to Block Eylea Biosimilar
August 29, 2024
 · 
2 min read
 · 
Tristan Manalac
Sign in front of Pfizer in Quebec, Canada
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
August 28, 2024
 · 
2 min read
 · 
Tristan Manalac
3D illustration of antibodies
Series A
Navigator Closes $100M Series A, Targets Autoimmune Market With Potential Best-in-Class Bispecific Antibody
August 28, 2024
 · 
2 min read
 · 
Tristan Manalac